"The global pharmaceutical industry is likely to experience a return to earnings growth in 2013 as fewer top-selling drugs lose their patent protection compared with last year," says Marie Fischer-Sabatie, the report's author, a vice president – senior credit officer in Moody's Corporate Finance Group. 

Embedded Link

Article > Global pharma to return to growth this year, says Moody’s
The outlook for the global pharmaceutical industry will remain stable over the next 12-18 months, reflecting the expectation of the sector returning to earnings growth this year, says rating agency Mo…

Google+: View post on Google+


Comments are closed.